Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBSM7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,384
Award facts
- Contract value 100% obligated
- $18,383.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,383.86 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens on December 9, 2025, with completion targeted for December 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, with extensive experience fulfilling diverse medication and medical supply requirements across the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates consistent capability in delivering brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities through competitively awarded delivery orders. This specific Zepbound procurement supports the military healthcare system's pharmaceutical needs, consistent with AmerisourceBergen's established role as a primary vendor for federal medical programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FBSM7?
SPE2DR26FBSM7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FBSM7 worth?
The government has obligated $18,384 on SPE2DR26FBSM7.
Is contract SPE2DR26FBSM7 an order under another contract?
Yes. SPE2DR26FBSM7 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSM7 competed?
The extent of competition for SPE2DR26FBSM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award